Skip to main content

ANNX

Stock
Health Care
Biotechnology

Performance overview

ANNX Price
Price Chart

Forward-looking statistics

Beta
0.76
Risk
79.72%

Detailed forecast

[disclaimer]

Individual forecast components (weighted-sum)

Company Profile

our mission is to develop disease-modifying therapeutics for patients suffering from neurological disorders such as huntington’s disease and alzheimer’s disease by targeting complement-mediated neurodegeneration (cmnd).

Company info

SectorHealth Care
IndustryBiotechnology
Employees78
Market cap$530.4M

Fundamentals

Enterprise value$27.9M
Revenue$0.0
Revenue per employee
Profit margin0.00%
Debt to equity11.61

Security info

ExchangeNASDAQ
Type of shareCommon Stock
Earnings per share (EPS)-$1.17
Dividend per share
Revenue per share
Avg trading volume (30 day)$4M
Avg trading volume (10 day)$4M
Put-call ratio

Macro factor sensitivity

Growth-0.1
Credit+27.8
Liquidity-9.3
Inflation-6.3
Commodities+0.4
Interest Rates+0.3

Valuation

Dividend yield0.00%
PEG Ratio-2.54
Price to sales
P/E Ratio-2.54
Enterprise Value to Revenue
Price to book1.30

Upcoming events

Next earnings dayMay 12, 2025
Next dividend day
Ex. dividend day

News

Are Medical Stocks Lagging Annexon (ANNX) This Year?

Here is how Annexon, Inc. (ANNX) and CareCloud, Inc. (CCLD) have performed compared to their sector so far this year.

Zacks Investment Research (June 28, 2024)
Annexon Touts Final Huntington's Trial Data Confirming No New Safety Issues

Annexon Inc (NASDAQ: ANNX) shared final data from the Phase 2 trial for ANX005 in patients with or at risk for Huntington's disease, which causes a progressive breakdown of nerve cells in the brain.  The 28 patients were dosed for six months and followed for three more.

Benzinga (June 7, 2022)

Unlock Personalized Financial Tools

All our core financial tools are completely free. Create an account to save your research, get personalized recommendations, and enjoy unlimited access.

Save research to draft portfolios
Get personalized recommendations
Access unlimited tool usage
Sign up for free